Predictors of Opioid Consumption in Immediate, Implant-Based Breast Reconstruction
- 1 October 2020
- journal article
- conference paper
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 146 (4) , 734-741
Abstract
Background: Current rates of opioid prescribing have deleterious consequences on both patient and societal levels. This study aims to evaluate responsible opioid prescribing and predictors of opioid consumption in immediate implant-based breast reconstruction. Methods: Patients undergoing consultation for immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at the preoperative and postoperative appointment to collect data on pain expectations and opioid use. A medical record review was performed. Results: Of 100 enrolled patients, 97 (97.0 percent) underwent surgery and 85 (85.0 percent) completed the postoperative survey. Preoperatively, 27 patients (27.0 percent) had a history of a chronic pain syndrome, 34 (34.0 percent) had a history of a mental health comorbidity, and nine (9.0 percent) had a history of active preoperative opioid use. A total of 85 tissue expander (87.6 percent) and 12 direct-to-implant (12.4 percent) reconstructions were completed. Patients were prescribed an average of 36.0 5-mg oxycodone tablets postoperatively. Patients reported consuming an average of 20.6 tablets, or 57.0 percent of the average prescription amount. The majority of patients (75.3 percent) reported taking an opioid less than once per day at the time of survey completion, and 24 patients (28.2 percent) reported that they did not use any opioids postoperatively. Preoperative opioid use (p= 0.004), inpatient opioid consumption (p< 0.0001), and patient-reported anxiety related to pain control (p< 0.05) were predictors of opioid consumption. Conclusions: Patients undergoing mastectomy and implant-based breast reconstruction are prescribed nearly twice as many opioid tablets as consumed, and one in three patients report not using any opioids postoperatively. Clinical factors may help guide prescribing practices.Keywords
This publication has 14 references indexed in Scilit:
- Assessment of Persistent and Prolonged Postoperative Opioid Use Among Patients Undergoing Plastic and Reconstructive SurgeryJAMA Facial Plastic Surgery, 2019
- Opioid Prescribing and Consumption Patterns following Outpatient Plastic Surgery ProceduresPlastic and Reconstructive Surgery, 2019
- Preoperative Multimodal Analgesia Decreases Postanesthesia Care Unit Narcotic Use and Pain Scores in Outpatient Breast SurgeryPlastic and Reconstructive Surgery, 2018
- New Persistent Opioid Use Among Patients With Cancer After Curative-Intent SurgeryJournal of Clinical Oncology, 2017
- Prescription Opioid Use among Opioid-Naive Women Undergoing Immediate Breast ReconstructionPlastic and Reconstructive Surgery, 2017
- Prescription Opioid Analgesics Commonly Unused After SurgeryJAMA Surgery, 2017
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US AdultsJAMA Surgery, 2017
- ASSIST - Patient satisfaction survey in postoperative pain management from Indian subcontinentJournal of Anaesthesiology Clinical Pharmacology, 2017
- A needs assessment of unused and expired medication disposal practices: A study from the Medication Safety Research Network of IndianaResearch in Social and Administrative Pharmacy, 2016
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009